Swami Om Bungalow, Bungalow No.-5, Singhad Road, Opp Bharti Sahakari Bank Ltd, near Shree Nagnath Furniture, Dhayri Phata, Pune – 411041
+91 9850826071
info@chemsis.co.in
We offer a large portfolio of high-quality primary antibodies that bind target proteins or other relevant antigens specifically and sensitively.
Recombinant antibodies can be genetically manipulated to offer higher quality and better performing reagents. They are known for their versatility by being suitable for a wide range of applications and being utilized in large scale or long-term experiments. Recombinant antibodies are available in diverse formats such as conjugated and purified forms with multiple species backbones, isotypes, and sub-types.
Recombinant antibodies (genetically engineered antibodies) are monoclonal antibodies generated by inserting modified antibody gene sequences into plasmids via recombinant DNA technology, and subsequently transfected into suitable host cells for protein expression
We offer over 5,000 mouse, rabbit, human, humanized and chimeric monoclonal recombinant antibodies.
Recombinant antibodies are antibodies that are generated in vitro through inserting cloned genes into expression vectors. The expression vector is then inserted into a host cell to express the antibody.
Our recombinant monoclonal antibody sequences are isolated from a pre-existing hybridoma, rabbit or llama antibody. By sequencing our antibodies and expressing them recombinantly we can provide an immortal supply with consistent results every time.
Start minimizing one major source of experimental variability in your research by using Chemsis Recombinant Antibodies.
We are addressing the challenges faced by researchers in proteomics, human health, and drug discovery by offering highly validated recombinant antibodies.
Specificity: Our antibodies undergo rigorous advanced verification through one or more different methods like relative expression, knockout analysis, and cell treatment. Currently, the portfolio houses thousands of advanced verified antibodies and we are in continuous pursuit to increase these numbers.
Outstanding performance and sensitivity: Engineered in various antibody backbones, our recombinant antibodies deliver heightened sensitivity and broader application compatibility, all while maintaining high specificity.
Versatility and scalability: Our antibodies are developed across multiple species and rigorously validated to support a variety of research applications. The recombinant production process enables consistent, large-scale batch manufacturing.
Reproducibility: Recombinant monoclonal antibodies exhibit exceptional lot-to-lot reproducibility because banked DNA does not exhibit a genetic drift—a phenomenon where hybridomas change expression patterns over time.
Rabbit recombinant monoclonal antibodies are identical immunoglobulins directed against a specific epitope. With a wide range of antibodies available, we offer solutions for various applications, including western blotting, immunocytochemistry, flow cytometry, and more.
Recombinant rabbit polyclonal antibodies consist of a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. These antibodies offer a unique advantage by combining the sensitivity of polyclonal antibodies with the specificity of monoclonal antibodies.
Recombinant antibodies, like monoclonal antibodies, can be used for the treatment of several diseases including autoimmune disorders and cancer. Recombinant antibodies have also been used to treat infectious diseases such as HIV-1, bacterial toxins, coronaviruses.
The quality, consistency, and specificity of a research antibody is essential for the reliability and reproducibility of pre-clinical research. Recombinant antibodies have high specificity, high sensitivity, and excellent batch-to-batch reproducibility and their use in biomedical research decreases experimental variability and enables high reproducibility.
